טוען...
Astragalus alters gut-microbiota composition in type 2 diabetes mice: clues to its pharmacology
Background: Astragalus possesses therapeutic effects for type 2 diabetes (T2D), while its action mechanisms remain to be elucidated. In view of the pathogenic associations between gut microbiota and T2D, we explored the effect of astragalus on gut-microbiota composition of T2D mice. Materials and me...
שמור ב:
| הוצא לאור ב: | Diabetes Metab Syndr Obes |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6529725/ https://ncbi.nlm.nih.gov/pubmed/31190935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S203239 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|